Design your protocol right first time. In challenging times such as these, speed is key: optimise trial design from the outset by moving RWD insights upstream.

Data is everywhere.

We describe ourselves as data-first companies. And in a time of Covid-19, data becomes an even more precious commodity.

Yet, in truth, how often are we using our data upfront, to design clinical protocols and get trials right in the first place?

The reality is that for all our talk, our trial designs get locked down before we can fully comprehend and incorporate the insights available through effective analysis of real world data. And this is a real missed opportunity.

Protocol design is already a complex process involving multiple stakeholders, CROs, vendors and other third parties. It’s a trying, manual process that regularly involves 10-20 iterations and multiple IT systems.

Now there is a better way. Smart, cloud-based systems promise to leverage both internal and external data assets around an enhanced trial design team, in a quick, yet flexible manner that prioritises interoperability, analysis and real world data for enhanced insights.

Join us for a free webinar where experts from pharma and IBM Watson Health guide us through a process that illustrates how upfront investment no longer has to be a risk; quite the opposite.